Using a patented retroviral technique, we can produce mAbs faster, more cost effectively, with high yields, and with greater cell line stability than conventional production methods. Our exclusive process is also useful for developing mAbs to problematic peptides.

Check out our new products.

NeoClone in the news.

NeoClone partners with Lucigen to launch Softag Protein Expression & Purification System. Read about the Softag system here.